RESEARCH NOTE
·
PYC Therapeutics Ltd (PYC)
An attractive opportunity to buy this drug development company.
Healthcare
Daily
ASX
This report is available to subscribers
The full research note on PYC Therapeutics Ltd — our view, the levels we are working to and the reasoning behind them — is part of a Kapitales subscription.